Alexey Maslyansky, MD, DSc


Head of Rheumatology and Immunopathology Research Laboratory

H-index (RSCI): 11; 97 publications in RSCI; 3 patents
ORCID ID: 0000—0003-2427-4148
Web of Science Researcher ID: G-7691—2018
Scopus: 55838512100

Focus areas: biomarkers of autoimmune diseases, immunosuppressive therapy for rheumatic diseases, autoinflammatory diseases.

1999 – graduated with honours from Pavlov State Medical University.

2000 – internship in Internal Medicine at the Department of Therapy and Rheumatology named after E. Eikhvald.

2001–2004 – full-time PhD student of the Department of Therapy and Rheumatology named after E. Eikhvald in internal medicine and allergology/immunology.

2007 – defended PhD thesis entitled “Clinical and immunological interactions in patients with rheumatoid arthritis resistant to ongoing therapy.”

2007 – Head of Allergology and Immunology Department of the Northwestern District Medical Center of Roszdrav.

2007–2011 –  Head of Rheumatology Department of Almazov Centre.

2011–2014 – a full-time doctoral student at Almazov Centre.

2019 – defended doctoral thesis entitled “Chronic inflammation, endothelial status and cardiovascular remodeling in patients with rheumatic diseases – the possibilities of pathogenetic therapy.”

2019 – Head of Rheumatology and Immunopathology Department

Personal achievements

Awarded the Certificate of Merit of the Ministry of Health and Social Development for contribution to healthcare.

Major publications

Relapsing evans syndrome and systemic lupus erythematosus with аntiphospholipid syndrome treated with bortezomib in combination with plasma exchange. Tkachenko O., Lapin S., Mikhailova L., Maslyansky A., Myachikova V., Gilburd B. Clinical Immunology. 2019. Т. 199. С. 44-46. IF 6.780. Access link:

Influence of HLA-DRB1 susceptibility alleles on the autoantibodies spectrum of systemic lupus erythematosus in European part of Russia. Tkachenko O., Lapin S., Guseva V., Mikhailova L., Maslyansky A., Myachikova V., Belolipetskaia E., Belyaeva I., Mazurov V., Ivanova N., Gilburd B. Autoimmunity Reviews. 2019. Т. 18. № 5. С. 558-560. doi: 10.1016/j.autrev.2019.03.013. IF 9.754. Access link:

Ventricular tachycardia as the first manifestation of Churg-Strauss syndrome. Budanova M., Mitrofanova L., Kozlenok A., Ryzhkova D., Maslyanskiy A., Moiseeva O. Journal Of Cardiology Cases. 2017. Т. 15. № 2. С. 61-64. doi: 10.1016/j.jccase.2016.10.011. IF 0.53. Access link:


Software Registration Certificate RU 2019617549, issued on 17.06.2019
“Software for automatic calculation of the daily dose of prednisolone or methylprednisolone under constant controlled decrease in the drug amount taken by the patient, with the option to save the calculation results in pdf and as an ics file, as well as with the patient-controlled function of sending the results to the user’s calendar”

Software Registration Certificate RU 2018614886, issued on 19.04.2018
“Software to determine the relative amount of methotrexate taken by a patient with rheumatic disease over a certain period of time”

Patent for invention RU 2390334 C1, issued on 27.05.2010, application No. 2008150070/14 dated 17.12.2008
“Treatment method for multiple sclerosis”
Authors: E. P. Evdoshenko, A. L. Maslyansky, L.G. Zaslavsky



Уведомляем вас, что в соответствии с Федеральным законом от 06.03.2006 № 35-ФЗ «О противодействии терроризму» в Центре Алмазова введен комплекс дополнительных мер по безопасности, направленный на предотвращение террористических актов. В целях обеспечения безопасности граждан и целостности объектов инфраструктуры при посещении Центра Алмазова проводится дополнительный личный осмотр, осмотр вещей и автотранспорта. Отказ от соблюдения мер по безопасности может послужить причиной недопуска на территорию Центра Алмазова. Просим с пониманием отнестись к введенным мерам по безопасности.

С уважением, Администрация Центра Алмазова